The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Innovations leads £5m Series A round in Aqdot

8 Feb 2016 07:00

RNS Number : 3045O
Imperial Innovations Group plc
08 February 2016
 

RNS REACH

8 February 2016

 

Imperial Innovations Group plc

 

Innovations leads £5m Series A round in encapsulation specialist Aqdot

 

Imperial Innovations Group plc (AIM: IVO, 'the Group', 'Innovations') has led a £5.0 million Series A funding round in portfolio company Aqdot Limited ('Aqdot' or the 'Company') the Cambridge (UK) based specialist chemical company.

 

Innovations has committed £3.0 million to the round alongside Cambridge Enterprise, Parkwalk Advisors and Providence Investment Company. Innovations first invested in the Company in November 2013 and has now invested a total of £4.6 million. As a result of this investment, Innovations will now hold a 46.5% (non-diluted) interest in the Company.

 

Aqdot operates in the rapidly growing encapsulation market, currently valued at £4 billion. Its proprietary technologies encapsulate and protect valuable active products (cargos) in a variety of settings. Uniquely, using a variety of triggers, this enables the release of cargos when and where the customer requires.

 

Aqdot is now engaged with customers across a number of sectors. Initially the Company is focusing on household products, fragrances and niche industrial applications. Future potential applications include agrochemicals and pharmaceuticals.

 

Kelsey Lynn Skinner, Director Technology Ventures at Innovations said:

 

"Aqdot has taken significant steps forward since the last funding round in particular in customer engagement and application-specific technology development.

 

"Aqdot has a strong team in place, and we are proud to lead this Series A round alongside our co-investors to enable the continued execution of the strategy."

 

For further information contact:

 

Imperial Innovations Group plc

020 3053 8834

Russ Cummings, Chief Executive Officer

Jon Davies, Director of Communications

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth Stanley/Alec Pratt

 

Cenkos Securities

020 7397 8900

Christopher Golden

 

 

Notes to editors

 

About Imperial Innovations - www.imperialinnovations.co.uk 

 

Imperial Innovations Group plc ("Innovations") creates, builds and invests in pioneering technology companies and licensing opportunities developed from outstanding scientific research from the 'Golden Triangle', the geographical region broadly bounded by London, Cambridge and Oxford. This area has an unrivalled cluster of outstanding academic research and technology businesses, and is home to four of the world's top 10 universities, as well as leading research institutions, the cream of the UK's science and technology businesses and many of its leading investors.

 

Innovations supports scientists and entrepreneurs in the commercialisation of their ideas, through the licensing of intellectual property, by leading the formation of new companies, by recruiting high-calibre management teams and by providing investment and encouraging co-investment. Innovations remains an active investor over the life of its portfolio companies, with the majority of Innovations' investment going into businesses in which it is already a shareholder.

 

Since becoming a public company in 2006, Innovations has raised more than £346.0 million of equity from investors, which has enabled it to invest in some of the most exciting spin-outs to come out of UK academic research. In addition, the Group has agreed £80.0 million in loan facilities from the European Investment Bank (EIB).

 

Between Innovations' admission to AIM (August 2006) and 31 July 2015, Innovations has invested a total of £236.8 million across its portfolio companies, which have raised collectively investment of £1.3 billion.

 

About Aqdot - www.aqdot.com

 

Aqdot is a specialist chemical company based in Cambridge (UK). The Company specialises in developing and commercialising disruptive encapsulation technologies that enable valuable actives (cargos) to be protected, delivered and released when required.

 

In this modern age we interact with encapsulated products throughout our day, be it the materials and fuels in our transportation, flavourings in our food, fragrances in our toiletries or the medicines we take. To date the challenge has been in triggering encapsulation systems to release their cargo when the customer needs them. For example, the release of stain removing enzymes from a biological washing detergent in low temperature washes. It is this unique proprietary capability that Aqdot's platform technology delivers.

 

This approach enables Aqdot's customers to increase product effectiveness, introduce novel and differentiated brands, reduce manufacturing costs and positively impact the environment. Originally spun out of Cambridge University, Aqdot is currently focused in developing products in the household, fragrance and niche industrial sectors. Future potential applications include agrochemicals and pharmaceuticals.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAVELFBQLFBBBZ
Date   Source Headline
27th Nov 20177:00 amRNSExercise of share options
27th Nov 20177:00 amRNSIssue of Equity
13th Nov 20177:01 amRNSBoard changes following cancellation of admission
13th Nov 20177:00 amRNSNotice of cancellation of admission to AIM
27th Oct 201710:54 amRNSPosting of Annual Report
26th Oct 20173:50 pmRNSIssue of Equity
18th Oct 201710:30 amRNSOffer Update; Appointment of Prof. David Begg
18th Oct 20179:38 amRNSUpdated recommendation by Touchstone Innovations
18th Oct 20177:00 amRNSOffer Update - Wholly Unconditional
17th Oct 20179:10 amRNSGrant of share options
17th Oct 20177:36 amRNSOffer Update - CMA clearance and Offer timetable
16th Oct 201710:54 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
9th Oct 20179:58 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
9th Oct 20177:00 amRNSOffer Update
5th Oct 20178:30 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
4th Oct 20177:00 amRNSTouchstone invests £1.4m in Featurespace round
2nd Oct 201710:32 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
29th Sep 20178:29 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
25th Sep 20179:15 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
21st Sep 20178:56 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
18th Sep 20177:00 amRNSOffer Update
13th Sep 20179:33 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
13th Sep 20177:00 amRNSFinal Results
12th Sep 20171:48 pmRNSForm 8.3 - Touchstone Innovations plc
12th Sep 20171:46 pmRNSForm 8.3 - Touchstone Innovations plc
12th Sep 201711:50 amRNSForm 8.3 - Touchstone Innovations Plc
12th Sep 201710:52 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
12th Sep 20177:00 amRNSTouchstone commits funds to Ieso Digital Health
11th Sep 20179:41 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
8th Sep 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
8th Sep 20178:51 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations PLC
7th Sep 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
7th Sep 20178:57 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations PLC
30th Aug 20176:21 pmRNSUpdate on Offer for Touchstone Innovations plc
25th Aug 201710:14 amRNSUpdate on Offer for Touchstone and Capital Raising
25th Aug 20179:56 amRNSStatement re: Offer timetable extended
21st Aug 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
17th Aug 20177:00 amRNSFurther re Capital Raising
16th Aug 20173:12 pmRNSForm 8.3 - IP Group Plc
15th Aug 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
1st Aug 20177:00 amRNSPublication of Response Circular
28th Jul 20172:21 pmRNSForm 8.3 - IP Group Plc
27th Jul 20172:52 pmRNSForm 8.3 - IP Group Plc
26th Jul 20172:20 pmRNSForm 8.3 - IP Group Plc
25th Jul 20175:38 pmRNSStatement re clarification of offer for Touchstone
25th Jul 201712:16 pmRNSForm 8.3 - Touchstone Innovations Plc
21st Jul 201712:43 pmRNSForm 8.3 - Touchstone Innovations Plc
20th Jul 201711:35 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
19th Jul 201711:42 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
19th Jul 201711:14 amRNSForm 8.3 - Touchstone Innovations Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.